FISHER & PAYKEL HEALTHCARE
Report
- Report Number
- 9611451-2025-00877
- Event Type
- Injury
- Date Received
- September 10, 2025
- Date of Event
- July 28, 2025
- Report Date
- September 10, 2025
- Manufacturer
- FISHER & PAYKEL HEALTHCARE LTD
- Product Code
- BTT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER
Narratives
(B)(6). D4, G4: PT101AZ IS NOT SOLD IN THE USA BUT IT IS SIMILAR TO A PRODUCT WHICH IS SOLD IN THE USA (PT101US). THE 510(K) FOR THE SIMILAR PRODUCT IS K131895. PRODUCT BACKGROUND: THE PT101 AIRVO 2 (AIRVO 2) DEVICE IS AN ACTIVE HUMIDIFIER WITH INTEGRATED FLOW GENERATOR THAT DELIVERS HIGH FLOW WARMED AND HUMIDIFIED RESPIRATORY GASES TO SPONTANEOUSLY BREATHING PATIENTS THROUGH A VARIETY OF PATIENT INTERFACES. IT'S INTENDED USE IS FOR THE TREATMENT OF SPONTANEOUSLY BREATHING PATIENTS WHO WOULD BENEFIT FROM RECEIVING HIGH FLOW WARMED AND HUMIDIFIED RESPIRATORY GASES. THE AIRVO 2 DEVICE SHOULD NOT BE USED FOR LIFE SUPPORT PURPOSES, AND APPROPRIATE PATIENT MONITORING MUST BE USED AT ALL TIMES. METHOD: THE SUBJECT DEVICE WAS NOT RETURNED TO F&P FOR EVALUATION. OUR INVESTIGATION IS BASED ON THE INFORMATION PROVIDED BY THE CUSTOMER, PREVIOUS INVESTIGATIONS OF SIMILAR COMPLAINTS, AND OUR KNOWLEDGE OF THE PRODUCT. RESULTS: THE HEALTHCARE FACILITY REPORTED THAT AFTER ADJUSTING THE SUBJECT DEVICE'S SETTINGS, THE PATIENT'S OXYGEN SATURATION LEVELS DECREASED TO 76%. DESPITE F&P'S MULTIPLE REQUESTS FOR FURTHER INFORMATION REGARDING THE EVENT, THE REQUESTED INFORMATION WAS NOT PROVIDED. CONCLUSION: ON THE BASIS OF THE LIMITED INFORMATION AVAILABLE AND THE DATE OF THE REPORTED EVENT, F&P'S INVESTIGATION WAS UNABLE TO DETERMINE THE CAUSE OF THE REPORTED EVENT. DURING THE MANUFACTURING PROCESS, QUALITY CONTROL MEASURES ENSURE EACH MANUFACTURED AIRVO 2 MEETS SPECIFICATION. THESE QUALITY CONTROL MEASURES ARE PERFORMED AT THE END OF THE FINAL ASSEMBLY PROCESS ON 100% OF THE MANUFACTURED UNITS. ANY UNIT THAT FAILS ANY OF THESE TESTS WILL BE REJECTED. THE SUBJECT DEVICE THEREFORE WOULD HAVE MET THE REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE. THE AIRVO 2 UI ALSO PROVIDES THE FOLLOWING WARNINGS: "THE UNIT IS NOT INTENDED FOR LIFE SUPPORT." "APPROPRIATE PATIENT MONITORING MUST BE USED AT ALL TIMES. LOSS OF POWER MEANS LOSS OF THERAPY." "USE CONTINUOUS OXYGEN MONITORING ON PATIENTS WHO WOULD DESATURATE SIGNIFICANTLY IN THE EVENT OF DISRUPTION TO THEIR OXYGEN SUPPLY." "NEVER OPERATE THE UNIT IF IT IS NOT WORKING PROPERLY."
A HEALTHCARE FACILITY IN CHINA REPORTED THAT ON (B)(6) 2025, A PATIENT WAS ADMINISTERED THERAPY ON A PT101 AIRVO 2 RESPIRATORY HUMIDIFIER (AIRVO 2). IT WAS REPORTED BY THE HEALTHCARE FACILITY THAT AFTER ADJUSTING THE SUBJECT DEVICE'S SETTINGS, THE PATIENT'S OXYGEN SATURATION LEVELS DECREASED TO 76%. IT WAS REPORTED THAT THE PATIENT WAS THEN MOVED ON TO A VENTILATOR. THERE WAS NO FURTHER PATIENT CONSEQUENCES REPORTED. FISHER AND PAYKEL HEALTHCARE (F&P) MADE MULTIPLE REQUESTS FOR FURTHER INFORMATION SUCH AS DETAILS ON THE SEQUENCE OF EVENTS AND PATIENT INFORMATION; HOWEVER, THE REQUESTED INFORMATION WAS NOT PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1952385 | FISHER & PAYKEL HEALTHCARE | RESPIRATORY HUMIDIFIER | BTT | FISHER & PAYKEL HEALTHCARE LTD | PT101AZ | 2102454027 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Other |